focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksROL.L Regulatory News (ROL)

  • There is currently no data for ROL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

17 Mar 2022 09:15

RNS Number : 1218F
Rotala PLC
17 March 2022
 

 

RNS

 

17 March 2022

 

 

Rotala Plc

("Rotala", the "Company" or the "Group")

 

Directors' dealings: Grant of Share Options

 

The Company announces that, on 16 March 2022, it granted options over a total of 3,200,000 ordinary shares of 25p each ("Ordinary Shares") in the capital of the Company (the "New Options"), all of which have an exercise price of 25.0 pence per share, to each of the Company's executive directors, Simon Dunn, Robert Dunn and Kim Taylor. The Board's Remuneration Committee decided to take this step in order to incentivise management as the Group recovers from COVID-19. Further details of the terms of the New Options are set out below.

 

Background

 

The Company has not made any awards to executive directors under the Rotala plc 2005 Share Option Scheme (the "Scheme"), except for grants of SAYE options, since 2014. The Scheme was established in 2005, when the Company was first admitted to trading on AIM, and was intended to encompass the issue of share options to the Board and senior management, as well as SAYE option grants to all levels of employees. The Scheme permits the issue of share options up to 13.47% of the total number of the Company's shares in issue (including, for these purposes, shares held in Treasury by the Company). The Company's current issued share capital is 50,924,918 Ordinary Shares, of which 800,000 are held in Treasury.

 

Prior to the grant of the New Options, the following share options were in issue:

 

Date of grant

Number of options granted

Earliest exercise date

Date of expiry

Exercise price

24 November 2014

1,910,000

24 November 2017

23 November 2024

54.0p

15 October 2021

800,000

15 October 2021

23 November 2024

29.0p

 

In respect of the issue of 24 November 2014, the share options are split into three equal tranches. For a tranche to be exercisable, the market price of the Ordinary Shares must have reached 65.0p, 80.0p and 95.0p respectively. At the date of this announcement, the market price vesting condition has been met only in respect of the first tranche.

 

In respect of the issue of 15 October 2021, for the share options to be exercisable, the market price of the Ordinary Shares must have reached 75.0p. At the date of this announcement, the market price vesting condition has not been met.

 

Each of Simon Dunn, Robert Dunn and Kim Taylor have been granted 2,000,000, 800,000 and 400,000 New Options respectively. For the New Options to be exercisable, the market price of the Ordinary Shares must have been sustained at prices between 56.0p and 62.0p per share over a period of at least 20 consecutive business days.

 

Options outstanding

 

Following the issue of the New Options, the following share options are now in issue:

 

Date of grant

Number of options granted

Earliest exercise date

Date of expiry

Exercise price

24 November 2014

1,910,000

24 November 2017

23 November 2024

54.0p

15 October 2021

800,000

15 October 2021

23 November 2024

29.0p

16 March 2022

3,200,000

16 March 2022

23 November 2024

25.0p

 

This amounts to a total of 5,910,000 share options, being 11.61% of the total number of the Company's shares in issue (including those held in Treasury). The Remuneration Committee decided to set the expiry date of the New Options to be the same as the existing share options so that the matter of share option awards could be considered afresh in November 2024.

 

After the grant of the New Options, the Company's executive directors hold the following options over Ordinary Shares:

 

Number of options granted

Earliest date exercisable

Date of expiry

Exercise price

Market price vesting condition

S Dunn

577,778

16/03/2022

23/11/2024

25.0p

56.0p

663,704

16/03/2022

23/11/2024

25.0p

60.0p

758,518

16/03/2022

23/11/2024

25.0p

62.0p

300,000

24/11/2017

23/11/2024

54.0p

65.0p

300,000

24/11/2017

23/11/2024

54.0p

80.0p

300,000

24/11/2017

23/11/2024

54.0p

95.0p

2,900,000

R Dunn

231,111

16/03/2022

23/11/2024

25.0p

56.0p

265,481

16/03/2022

23/11/2024

25.0p

60.0p

303,408

16/03/2022

23/11/2024

25.0p

62.0p

205,000

24/11/2017

23/11/2024

54.0p

65.0p

205,000

24/11/2017

23/11/2024

54.0p

80.0p

205,000

24/11/2017

23/11/2024

54.0p

95.0p

1,415,000

K Taylor

115,556

16/03/2022

23/11/2024

25.0p

56.0p

132,741

16/03/2022

23/11/2024

25.0p

60.0p

151,703

16/03/2022

23/11/2024

25.0p

62.0p

131,666

24/11/2017

23/11/2024

54.0p

65.0p

131,667

24/11/2017

23/11/2024

54.0p

80.0p

131,667

24/11/2017

23/11/2024

54.0p

95.0p

795,000

 

The remaining 800,000 share options in issue are held by senior management who are not members of the Board of Rotala.

 

 

Rotala Plc

0121 322 2222

Graham Spooner, Deputy Chairman and Chairman of the Remuneration CommitteeSimon Dunn, Chief ExecutiveKim Taylor, Group Finance Director

 

Shore Capital

 

020 7408 4090

Tom Griffiths / James Thomas / Michael McGloin (Corporate Advisory)Henry Willcocks (Corporate Broking)

About the business 

Rotala provides a range of transport solutions, ranging from local bus services under contract to local authorities, through to commercial bus routes. Rotala has operations at Heathrow Airport, in the West Midlands and in the North West. Operating companies are Diamond Bus Ltd, Diamond Bus (North West) Ltd, Hallmark Connections Ltd and Preston Bus Ltd.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKOBDCBKKNND
Date   Source Headline
20th May 202011:54 amRNSAnnual Financial Report
4th May 202011:55 amRNSDirector/PDMR Shareholding
27th Apr 20208:45 amRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSFinal Results
9th Apr 20207:00 amRNSTrading Statement
27th Jan 20207:00 amRNSTrading Statement
2nd Jan 202010:55 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSDirector/PDMR Shareholding
18th Oct 20199:37 amRNSShare Subscription and Director Dealing
7th Oct 20192:52 pmRNSHolding(s) in Company
2nd Oct 20192:47 pmRNSIssue of Equity
22nd Aug 20197:00 amRNSHalf-year Report
21st Aug 201912:35 pmRNSSubscription of Ordinary Shares
12th Aug 20191:42 pmRNSCompletion of Acquisition
6th Aug 20191:54 pmRNSHolding(s) in Company
2nd Aug 201912:24 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSPlacing and Subscription
27th Jun 20197:00 amRNSAcquisition in Manchester
29th May 20194:57 pmRNSResult of AGM
7th May 20197:00 amRNSAnnual Financial Report
2nd Apr 20197:00 amRNSFinal Results
23rd Jan 20197:00 amRNSPre-close trading statement
2nd Jan 20194:03 pmRNSDirector/PDMR Shareholding
30th Nov 20187:00 amRNSSale of Freehold Depot and Fuel Hedging update
1st Nov 20181:54 pmRNSHolding(s) in Company
1st Nov 20181:50 pmRNSDirector/PDMR Shareholding
28th Aug 20184:09 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSHalf-year Report
20th Jul 201811:30 amRNSHolding(s) in Company
29th May 20185:00 pmRNSResult of AGM
4th May 201810:41 amRNSPosting of Annual Report and Notice of AGM
1st May 201812:10 pmRNSHolding(s) in Company
30th Apr 20182:49 pmRNSDirector/PDMR Shareholding
30th Apr 20182:46 pmRNSDirector/PDMR Shareholding
24th Apr 20185:42 pmRNSDirector/PDMR Shareholding
19th Apr 20186:20 pmRNSDirector/PDMR Shareholding
12th Apr 20185:55 pmRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSFinal Results
23rd Feb 20184:44 pmRNSHolding(s) in Company
22nd Feb 201812:48 pmRNSHolding(s) in Company
2nd Feb 20187:00 amRNSPre-close trading statement
19th Dec 20174:29 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSCompletion of Acquisition
17th Oct 20172:30 pmRNSAcquisition
1st Sep 20173:56 pmRNSCompletion of Acquisition
25th Aug 201710:55 amRNSFurther re. Fund Raise and Acquisitions
22nd Aug 201711:47 amRNSHolding(s) in Company
18th Aug 201712:50 pmRNSResult of General Meeting and Issue of Equity
11th Aug 20177:00 amRNSDirectorate Change
11th Aug 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.